Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001144204-15-070174
Filing Date
2015-12-09
Accepted
2015-12-09 17:26:34
Documents
1
Effectiveness Date
2015-12-09

Document Format Files

Seq Description Document Type Size
1 DFAN14A v426597_dfan14a.htm DFAN14A 59457
  Complete submission text file 0001144204-15-070174.txt   61343
Mailing Address 546 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10036
Business Address 41 DOVER STREET LONDON A1 W1S 4NS 212-953-4952
LAIDLAW & COMPANY (UK) LTD. (Filed by) CIK: 0001146350 (see all company filings)

State of Incorp.: XX | Fiscal Year End: 1231
Type: DFAN14A

Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Subject) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DFAN14A | Act: 34 | File No.: 000-55347 | Film No.: 151279125
SIC: 2834 Pharmaceutical Preparations